Back to Search
Start Over
Prognostic impact of maximum standardized uptake value on <scp> 18 F‐FDG PET </scp> / <scp>CT</scp> imaging of the primary lung lesion on survival in advanced non‐small cell lung cancer: A retrospective study
- Source :
- Thoracic Cancer. 12:845-853
- Publication Year :
- 2021
- Publisher :
- Wiley, 2021.
-
Abstract
- Background Positron emission tomography/computed tomography (PET/CT) has been recognized for diagnosing and staging lung cancer, but the prognostic value of standardized uptake value (SUV) on 18 F-FDG PET/CT imaging in patients with advanced non-small cell lung cancer (NSCLC) remains controversial. Methods We performed a retrospective analysis of patients with advanced NSCLC who had undergone 18 F-FDG PET/CT before systemic treatment between June 2012 and June 2016. The relationship between the maximum SUV (SUVmax) of the pulmonary lesion and lesion size was evaluated via Spearman's correlation analysis. We collected patients' clinical and pathological data. Univariate and multivariate analyses were performed to analyze the factors influencing survival. Results We included 157 patients with advanced NSCLC. Among these, 135 died, 13 survived, and nine were lost to follow-up (median follow-up period, 69 months). SUVmax was correlated with lesion size and was significantly greater for tumors ≥3 cm than for tumors 6 (HR = 0.651, 95% confidence interval, 0.436-0.972; Wald value, 4.400; p = 0.036). Conclusions The SUVmax of the primary lung lesion on PET/CT is significantly correlated with survival in treatment-naive patients with advanced NSCLC.
- Subjects :
- 0301 basic medicine
Pulmonary and Respiratory Medicine
medicine.medical_specialty
Multivariate analysis
medicine.diagnostic_test
business.industry
Standardized uptake value
Retrospective cohort study
General Medicine
medicine.disease
Confidence interval
Lesion
03 medical and health sciences
030104 developmental biology
0302 clinical medicine
Oncology
Positron emission tomography
030220 oncology & carcinogenesis
medicine
Radiology
medicine.symptom
Lung cancer
business
Pathological
Subjects
Details
- ISSN :
- 17597714 and 17597706
- Volume :
- 12
- Database :
- OpenAIRE
- Journal :
- Thoracic Cancer
- Accession number :
- edsair.doi...........af869da7845b756ebe1efbe9dd156b56
- Full Text :
- https://doi.org/10.1111/1759-7714.13863